HealthPartners NeuroWell Exercise Program for Spinal Cord Injuries

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
HealthPartners Neuroscience Center, Saint Paul, MN
Spinal Cord Injuries+1 More
HealthPartners NeuroWell Exercise Program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Long lasting inflammation in the body is related to cardiovascular and respiratory disease, which are the two most common causes of death in people living with spinal cord injury (SCI). Individuals with SCI have been reported to have higher levels of inflammation when compared to healthy individuals. Exercise is a well-known method to reduce inflammation; however, people with SCI are often inactive. The main goal of this study is to determine whether a 12-week adaptive exercise program can reduce inflammation in people with SCI. Participants will be randomized to start exercise immediately or after a 12-week delay.

Eligible Conditions

  • Spinal Cord Injuries

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Spinal Cord Injuries

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 12 weeks

12 weeks
Effect of exercise on inflammation
Effect of exercise on inflammation (C-reactive protein)
Effect of exercise on inflammation (Interleukin 6)
Effect of exercise on inflammation (Tumor Necrosis)

Trial Safety

Safety Progress

1 of 3

Other trials for Spinal Cord Injuries

Trial Design

2 Treatment Groups

Delayed start
1 of 2
Immediate start
1 of 2
Active Control
Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: HealthPartners NeuroWell Exercise Program · No Placebo Group · N/A

Immediate start
Behavioral
Experimental Group · 1 Intervention: HealthPartners NeuroWell Exercise Program · Intervention Types: Behavioral
Delayed start
Behavioral
ActiveComparator Group · 1 Intervention: HealthPartners NeuroWell Exercise Program · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks
Closest Location: HealthPartners Neuroscience Center · Saint Paul, MN
2018First Recorded Clinical Trial
1 TrialsResearching Spinal Cord Injuries
5 CompletedClinical Trials

Who is running the clinical trial?

HealthPartners InstituteLead Sponsor
164 Previous Clinical Trials
4,905,774 Total Patients Enrolled
Amanda A Herrmann, PhDPrincipal InvestigatorHealthPartners Neuroscience Research
2 Previous Clinical Trials
56 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a female age 18-70 years old.
You are able to achieve at least 90° active shoulder flexion, in order to complete study activities.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.